Welcome to our dedicated page for Cellev8 Nutrition news (Ticker: CELV), a resource for investors and traders seeking the latest updates and insights on Cellev8 Nutrition stock.
Cellev8 Nutrition Inc. reports developments around its SOD-based wellness and nutrition supplement business, including corporate name-change activity, product launches, patent filings, partnerships, and governance updates.
The company’s news centers on Cellev8 formulations that use Superoxide Dismutase (SOD) and patent-pending gummy delivery systems for cellular wellness, recovery, performance, metabolic support, sleep-related wellness, and antioxidant support. Updates have also covered SlimCell™, athlete-focused marketing partnerships, joint marketing with Vivos Therapeutics, and additions to the board tied to scientific and medical expertise.
Summary not available.